Jones Jeffrey Alan's Insider Trades & SAST Disclosures
Jones Jeffrey Alan's most recent trade in Cullinan Oncology Inc was a trade of 4,895 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jones Jeffrey Alan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 4,895 | 174,164 | - | 8.5 | 41,754 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 65,000 | 179,059 | - | 0 | Common Stock | |
| Whitestone REIT | Alan Jones Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 14.15 per share. | 24 Dec 2024 | 5,831 | 33,110 (0%) | 0% | 14.2 | 82,509 | Common Shares |
| Cullinan Oncology Inc | Jeffrey Jones Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,632 | 114,059 | - | 11.4 | 52,851 | Common Stock |
| Cullinan Oncology Inc | Alan Jones Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jones Alan Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 62,500 | 118,691 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jones Jeffrey Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,860 | 56,191 | - | 8.5 | 15,810 | Common Stock |
| Whitestone REIT | Alan Jeffrey Jones | Director | Grant, award, or other acquisition of securities at price $ 12.44 per share. | 20 Dec 2023 | 4,824 | 27,279 (0%) | 0% | 12.4 | 60,011 | Common Shares |
| Cullinan Oncology Inc | Jones Alan Jeffrey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 386 | 58,051 | - | 8.2 | 3,173 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 387 | 58,437 | - | 12.9 | 5,008 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 394 | 58,824 | - | 8.8 | 3,451 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 392 | 59,218 | - | 10.7 | 4,198 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 390 | 59,610 | - | 11.3 | 4,415 | Common Stock |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Whitestone REIT | Jeffrey Alan Jones | Director | Grant, award, or other acquisition of securities at price $ 9.52 per share. | 19 Dec 2022 | 6,303 | 22,455 (0%) | 0% | 9.5 | 60,005 | Common Shares |
| Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Whitestone REIT | Jeffrey Alan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 5,365 | 16,152 (0%) | 0% | 0 | Common Shares | |
| Whitestone REIT | Jeffrey Alan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2020 | 4,537 | 10,787 (0%) | 0% | 0 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges